Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05143931 · ClinicalTrials.gov registry record · NA
Avoid and Resist Strategies for Weight Management
A NA study of Obesity and Overweight, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 503
- Enrollment target
- 1
- Study location
NCT05143931: Recruiting NA study of Obesity and Overweight, sponsored by Cedars-Sinai Medical Center.
NCT05143931 is a NA study of Obesity and Overweight that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 503 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05143931, a NA study of Obesity and Overweight, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 503 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed randomized controlled trial tests two self-regulatory approaches to improve intentional weight loss and diet quality in individuals with overweight or obesity: (1) an environmental control strategy (AVOID) and (2) an impulse control training strategy (RESIST).
Primary Outcome
BMI will be calculated by aggregating participants' self-reported height in meters and weight in kilograms at baseline, 6- and 12-months.
Conditions Studied
Interventions
- BEHAVIORAL Home food environment and grocery delivery (AVOID)
- BEHAVIORAL Inhibitory control training (RESIST)
- BEHAVIORAL WW
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 503 participants |
| Start Date | 2022-06-06 |
| Est. Completion | 2027-02-09 |
| Phase | NA |
What NCT05143931 shows while recruiting
NCT05143931 is an interventional study that assigns participants to a tested intervention. The registered 503 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (39% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Home food environment and grocery delivery (AVOID) is the first listed.
NCT05143931 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05143931 about?
NCT05143931 is a clinical study titled "Avoid and Resist Strategies for Weight Management". The proposed randomized controlled trial tests two self-regulatory approaches to improve intentional weight loss and diet quality in individuals with overweight or obesity: (1) an environmental control strategy (AVOID) and (2) an impulse control training strategy (RESIST).
What is the current status of trial NCT05143931?
This trial is currently recruiting. It is a NA study. The enrollment target is 503 participants. The study started on 2022-06-06. Estimated completion is 2027-02-09.
What conditions does trial NCT05143931 study?
This clinical trial studies the following conditions: Obesity, Overweight.
What interventions are being tested in trial NCT05143931?
The interventions under investigation include: Home food environment and grocery delivery (AVOID) (BEHAVIORAL), Inhibitory control training (RESIST) (BEHAVIORAL), WW (BEHAVIORAL).
Who is sponsoring clinical trial NCT05143931?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05143931 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05143931's enrollment target sits among peer trials
503 134th of 1053 higher than 920 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05846282 · 504 participants · NA
Students Rising Above: Offsetting the Health and Mental Health Costs of Resilience
- NCT06072131 · 504 participants · Phase 3
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
- NCT06736522 · 504 participants · NA
Future Leaders Program: Testing a Youth Leadership, Engagement, and Mindfulness Program
- NCT06822257 · 504 participants · NA
Drinking in Young Adult Duos (DYAD) Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI